LP Columns: More Than Just Tolerating Strong Acids

LP Columns: More Than Just Tolerating Strong Acids

Introduction

The Ultisil family, being Welch Materials' flagship series, has earned broad acceptance across customers worldwide. Within that family, the LP (Low pH) subseries commonly evokes a single, immediate association: resistance to strong acids.

While this association is correct, it only scratches the surface. The LP series’ performance arises from an integrated set of design choices that deliver acid stability while also providing distinctive and useful chromatographic selectivity, and is rooted in three fundamental design elements:

  • the introduction of large functional groups on the alkyl side chains;
  • a re-hydroxylated silica surface; and
  • a deliberate lack of endcapping.

The following discussion examines these elements and explains how they translate into practical advantages for method development.

Large Functional Groups Introduced by Alkyl Side Chains

The degradation of traditional silica-based columns in acidic environments is primarily caused by the hydrolysis of the bonded phase. While the silica matrix itself is acid-resistant, the functional groups—both the primary stationary phase and the endcapping—are susceptible to cleavage.

The LP series addresses this vulnerability by introducing comparatively large functional groups into the alkyl side chains of the bonded phase. These bulkier substituents create steric hindrance that protects the bonded phase from hydrolytic attack under high-temperature, strongly acidic conditions, improving stability in precisely those environments that commonly accelerate degradation.

Beyond protection, these bulky groups provide additional chromatographic benefits through their stronger hydrophobicity and unique spatial structure. As a result, interactions with weakly polar regions of analyte molecules are often significantly stronger than with conventional bonded phases, and special selectivity toward certain structural motifs can be exhibited. Consequently, even though LP phases generally have lower bonding density, their retention of weakly polar compounds is not compromised.

The Omission of Endcapping

Welch Materials utilizes a “straightforward” approach to the vulnerability of endcapping groups for the LP series: they are entirely non-endcapped.

The omission of small endcapping groups may at first appear counterintuitive; conventional wisdom suggests that non-endcapped columns lead to peak tailing of basic compounds due to ionized silanols. That simple statement, however, implicitly requires both the silanols and the analytes to be ionized simultaneously—a condition that only occurs within a specific pH range. 

A chromatogram showing a tailing peak

However, even beyond this pH range, peak tailing and asymmetry still arise as a result of a more complex set of causes, hereby summarized as “multiple interactions where at least one force is in an overloaded state”.

By viewing the absence of endcapping not as a defect, but as an additional selective force, chromatographers can utilize:

  • Strengthened Hydrogen Bonding: Highly effective under acidic conditions.
  • Weak Ion Exchange: Available at near-neutral pH levels.
  • Increased Hydrophilicity: Providing a distinct advantage over traditional endcapped reversed-phase columns for polar interactions.

Don't these characteristics make method development more vivid? By embracing these natural silanol interactions rather than attempting to mask them with unstable endcapping, the LP series provides “special selectivity” that has been widely validated by the market.

Structure formula of a silica-based stationary phase

Re-hydroxylated Silica Surface

The final, and perhaps most critical, design element is the re-hydroxylated silica surface. While it looked indirect at first glance, it is the most essential process of the LP series, because non-endcapped columns are inherently more sensitive to variations in the underlying silica batches.

The re-hydroxylation process, introduced during column production, treats the silica substrate to eliminate micropores that contribute to reduced column efficiency, and create a smooth surface with a reduced density and uniform distribution of highly acidic silanol sites. As a result, the complex set of interaction mechanisms intrinsic to LP phases is stabilized and batch variability is minimized.

By controlling the silica surface in this way, Welch Materials increases the reproducibility and predictability of LP column behavior, creating a firmer foundation for reproducible method development that leverages the LP series’ distinctive selectivity.

Conclusion

From the design choices described above emerges a consistent philosophy: recognize the intrinsic complexity of the LP stationary phase and make deliberate engineering choices to stabilize and harness that complexity. The LP series is not merely a “strong-acid-tolerant” column family; it is a deliberately crafted stationary phase that combines sterically protected bonded groups, non-endcapped surface functionality, and a re-hydroxylated substrate to deliver acid stability, unique retention behavior for weakly polar analytes, and reduced batch variability.

For method developers, that means treating LP columns as tools with additional interaction modes to exploit—not as aberrant or defective phases to be avoided. When these modes are understood and applied, they broaden the options available during method development and can convert potential disadvantages into reliable, reproducible advantages.

Extra Chapter: LP-C18 in Isomer and Chiral Resolution

Ultisil LP-C18 has been found to also exhibit astonishing performance in isomer and chiral resolution. Below are some application examples.

Application Example 1: Separation of Amino Acid Isomers

  • Column: Ultisil LP-C18, 4.6×250 mm, 3 µm
  • Mobile Phase: K2HPO4 + ACN + MeOH
  • Flow Rate: 1.0 mL/min
  • Injection Volume: 10 µL
  • Column Temperature: 65 °C
  • UV Wavelength: 214 nm
Chromatogram of amino acid isomers separation

Note: One amino acid in the sequence of this drug intermediate is Asp, and the impurity is β-Asp. No tendency of separation was observed with XS-C18, XB-C18, and C30; only LP-C18 was able to separate them.

Application Example 2: Separation of Chiral Compounds

  • Column: Ultisil LP-C18, 4.6×250 mm, 5 µm
  • Mobile Phase: A: NaH2PO4 + NaSBE-β-CD, B: MeOH
  • Flow Rate: 0.8 mL/min
  • Injection Volume: 10 µL
  • Column Temperature: 30 °C
  • UV Wavelength: 205 nm
Chromatogram of chiral compounds separation
Column Ret. Time (min) Res. (EP) Plates (EP)
Ultisil LP-C18 18.595 1.67 18922
19.808 n.a 7548

Note: in this application, LP-C18 is more cost-effective than chiral columns.

Application Example 3: Separation of Argatroban Isomers (per USP 43)

  • Column: Ultisil LP-C18, 4.6×250 mm, 3 µm
  • Mobile Phase: MeOH / Water
  • Flow Rate: 0.6 mL/min
  • Injection Volume: 10 µL
  • Column Temperature: 50 °C
  • UV Wavelength: 259 nm
Chromatogram of argatroban isomers separation
Column Ret. Time (min) Res. (EP) Plates (EP)
Ultisil LP-C18 45.669 - 16639
48.208 1.764 17393

Note: We compared LP-C18 with XS-C18, PFP, C30, and Ultisil chiral columns; LP-C18 is more cost-effective and stable, with better reproducibility.